Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)’s traded shares stood at 0.76 million during the last session, with the company’s beta value hitting 0.19. At the close of trading, the stock’s price was $289.96, to imply an increase of 0.33% or $0.96 in intraday trading. The ALNY share’s 52-week high remains $304.39, putting it -4.98% down since that peak but still an impressive 49.38% since price per share fell to its 52-week low of $146.79.
Analysts have given a consensus recommendation of Buy for Alnylam Pharmaceuticals Inc (ALNY), translating to a mean rating of 1.74. Of 20 analyst(s) looking at the stock, 0 analyst(s) give ALNY a Sell rating. 0 of those analysts rate the stock as Overweight while 4 advise Hold as 16 recommend it as a Buy.
Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) trade information
After registering a 0.33% upside in the last session, Alnylam Pharmaceuticals Inc (ALNY) has traded red over the past five days. The 5-day price performance for the stock is 1.63%, and 19.52% over 30 days. With these gigs, the year-to-date price performance is 23.22%.
The extremes give us $310 and $338 for target low and target high price respectively. As such, ALNY has been trading -16.57% off suggested target high and -6.91% from its likely low.
ALNY Dividends
Alnylam Pharmaceuticals Inc has its next earnings report out in June. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
The next major institution holding the largest number of shares is VANGUARD GROUP INC with 12.51 million shares, or about 9.8694% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $3.04 billion.
We also have GROWTH FUND OF AMERICA and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund as the top two Mutual Funds with the largest holdings of the Alnylam Pharmaceuticals Inc (ALNY) shares. Going by data provided on Mar 31, 2025 , GROWTH FUND OF AMERICA holds roughly 10.18 shares. This is just over 7.81% of the total shares, with a market valuation of $2.95 billion. Data from the same date shows that the other fund manager holds a little less at 4.04, or 3.10% of the shares, all valued at about 1.17 billion.
